All Stories

  1. The role of PAF in immunopathology: From immediate hypersensitivity reactions to fungal defense
  2. Fungal Patterns Induce Cytokine Expression through Fluxes of Metabolic Intermediates That Support Glycolysis and Oxidative Phosphorylation
  3. Interferons Are Pro-Inflammatory Cytokines in Sheared-Stressed Human Aortic Valve Endothelial Cells
  4. Clinically used JAK inhibitor blunts dsRNA‐induced inflammation and calcification in aortic valve interstitial cells
  5. IRE1α–XBP1 signaling in leukocytes controls prostaglandin biosynthesis and pain
  6. Tricarboxylic Acid Cycle Activity and Remodeling of Glycerophosphocholine Lipids Support Cytokine Induction in Response to Fungal Patterns
  7. Polymorphisms in Receptors Involved in Opsonic and Nonopsonic Phagocytosis, and Correlation with Risk of Infection in Oncohematology Patients
  8. Calcification Induced by Type I Interferon in Human Aortic Valve Interstitial Cells Is Larger in Males and Blunted by a Janus Kinase Inhibitor
  9. Toll-Like Receptors, Inflammation, and Calcific Aortic Valve Disease
  10. Endoplasmic Reticulum Stress Sensor IRE1α Enhances IL-23 Expression by Human Dendritic Cells
  11. Fungal pattern receptors down-regulate the inflammatory response by a cross-inhibitory mechanism independent of interleukin-10 production
  12. Pharmacological inhibition of eicosanoids and platelet-activating factor signaling impairs zymosan-induced release of IL-23 by dendritic cells
  13. Synergy between Sphingosine 1-Phosphate and Lipopolysaccharide Signaling Promotes an Inflammatory, Angiogenic and Osteogenic Response in Human Aortic Valve Interstitial Cells
  14. Proline‐serine‐threonine phosphatase interacting protein 1 inhibition of T‐cell receptor signaling depends on its SH3 domain
  15. The Unfolded Protein Response and the Phosphorylations of Activating Transcription Factor 2 in the trans-Activation of il23a Promoter Produced by β-Glucans
  16. The Response of Human Macrophages to β-Glucans Depends on the Inflammatory Milieu
  17. The Autoimmunity Risk Variant LYP-W620 Cooperates with CSK in the Regulation of TCR Signaling
  18. Sirtuin 1 Is a Key Regulator of the Interleukin-12 p70/Interleukin-23 Balance in Human Dendritic Cells
  19. Viral and bacterial patterns induce TLR-mediated sustained inflammation and calcification in aortic valve interstitial cells
  20. Apoptotic cells enhance IL-10 and reduce IL-23 production in human dendritic cells treated with zymosan
  21. Notch- and Transducin-like Enhancer of Split (TLE)-dependent Histone Deacetylation Explain Interleukin 12 (IL-12) p70 Inhibition by Zymosan
  22. Eicosanoids in the Innate Immune Response: TLR and Non-TLR Routes
  23. Characterization of New Substrates Targeted By Yersinia Tyrosine Phosphatase YopH
  24. KCTD5, a putative substrate adaptor for cullin3 ubiquitin ligases
  25. Estudio de la expresión de interleucina-8 en el tejido pulmonar durante la isquemia-reperfusión
  26. Mannan and peptidoglycan induce COX‐2 protein in human PMN via the mammalian target of rapamycin
  27. Interleukin-8 Expression in Lung Tissue During Ischemia-Reperfusion
  28. Muscarinic Acetylcholine Receptor Enhances Phosphatidylcholine Hydrolysis via Phospholipase D in Bovine Chromaffin Cells in Culture
  29. Immune Complex Processing: A Phagocytosis-Based Mechanism with Proinflammatory Potential
  30. Blood and endothelium in immune complex-mediated tissue injury
  31. Biological effects of group IIA secreted phosholipase A2
  32. FcγR receptors activate MAP kinase and up-regulate the cyclooxygenase pathway without increasing arachidonic acid release in monocytic cells
  33. Signaling Mechanisms Involved in the Activation of Arachidonic Acid Metabolism in Human Astrocytoma Cells by Tumor Necrosis Factor-α
  34. Lysophosphatidic Acid Inhibits Ca2+ Signaling in Response to Epidermal Growth Factor Receptor Stimulation in Human Astrocytoma Cells by a Mechanism Involving Phospholipase Cγ and a Gαi Protein
  35. Brucella Lipopolysaccharides Induce Cyclooxygenase-2 Expression in Monocytic Cells
  36. FcγRIIA exogenously expressed in HeLa cells activates the mitogen-activated protein kinase cascade by a mechanism dependent on the endogenous expression of the protein tyrosine kinaseSyk
  37. Effect of 4‐trifluoromethyl derivatives of salicylate on nuclear factor κB‐dependent transcription in human astrocytoma cells
  38. Cytosolic phospholipase A2 and the distinct transcriptional programs of astrocytoma cells
  39. Secretory Phospholipase A2 Induces Phospholipase Cγ-1 Activation and Ca2+ Mobilization in the Human Astrocytoma Cell Line 1321N1 by a Mechanism Independent of Its Catalytic Activity
  40. 4-trifluoromethyl derivatives of salicylate, triflusal and its main metabolite 2-hydroxy-4-trifluoromethylbenzoic acid, are potent inhibitors of nuclear factor κB activation
  41. Immunoglobulin-E/Dinitrophenyl Complexes Induce Nitric Oxide Synthesis in Rat Peritoneal Macrophages by a Mechanism Involving CD23 and NF-κB Activation
  42. Thrombin produces phosphorylation of cytosolic phospholipase A2 by a mitogen-activated protein kinase kinase-independent mechanism in the human astrocytoma cell line 1321N1
  43. Cytosolic phospholipase A2 is coupled to muscarinic receptors in the human astrocytoma cell line 1321N1: characterization of the transducing mechanism
  44. The expression of cytokine-induced neutrophil chemoattractants (CINC-1 and CINC-2) in rat peritoneal macrophages is triggered by Fcγ receptor activation: Study of the signaling mechanism
  45. Lack of platelet-activating factor release on acute myocardial ischemia in the isolated interventricular septum of rabbit heart
  46. Platelet-activating factor: the effector of protein-rich plasma extravasation and nitric oxide synthase induction in rat immune complex peritonitis
  47. Study of the effector mechanism involved in the production of haemorrhagic necrosis of the small intestine in rat passive anaphylaxis
  48. Study of Some Mechanisms that may Contribute to the Presence of High Levels of Phospholipase A2 Activity in Plasma of Patients with Septicemia
  49. Effect of immunological stimulation on the production of platelet-activating factor by rat peritoneal cells: its relevance to anaphylactic reactions
  50. REPLY FROM M.C. GARCIA, M. G. LOPEZ, A. G. GARCIA, AND M. SANCHEZ CRESPO
  51. The role of platelet-activating factor and peptidoleukotrienes in the vascular changes of rat passive anaphylaxis
  52. Platelet-activating factor antagonists do not protect against the development of experimental autoimmune encephalomyelitis
  53. Occupancy of platelet receptors for platelet-activating factor in patients with septicemia.
  54. Intracellular localization of platelet-activating factor synthesis in human neutrophils
  55. Role of PAF-acether in the mediation of pathophysiological responses to aggregated immunoglobulins. Studies with the platelet-activating factor receptor antagonist BN 52021
  56. Platelet-Activating Factor: A Secretory Product from Phagocytes
  57. Inhibition of the vascular actions of IgG aggregates by BN 52021, a highly specific antagonist of paf-acether
  58. Modulation of lyso-platelet activating factor:acetyl-CoA acetyltransferase from rat splenic microsomes. The role of cyclic AMP-dependent protein kinase
  59. Modulation of lyso-platelet-activating factor:acetyl-CoA acetyltransferase from rat splenic microsomes. The role of calcium ions
  60. Synthesis of PAF-acether and blood volume changes in gram-negative sepsis
  61. Platelet-activating factor: An effector substance of the vasopermeability changes induced by the infusion of immune aggregates in the mouse
  62. Phospholipid turnover during phagocytosis in human polymorphonuclear leucocytes
  63. Vascular actions of synthetic PAF-acether (a synthetic platelet-activating factor) in the rat: Evidence for a platelet independent mechanism
  64. Inhibition of phospholipid methyltransferase during zymosan induced secretion of platelet-activating factor in human polymorphonuclear leukocytes
  65. Immunological Aspects of Renal Vascular Involvement
  66. IN-VITRO BASOPHIL DEGRANULATION IN DRUG-SUSPECTED ACUTE RENAL FAILURE